Narin Voravud

2.5k total citations
65 papers, 2.0k citations indexed

About

Narin Voravud is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Narin Voravud has authored 65 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 17 papers in Molecular Biology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Narin Voravud's work include Head and Neck Cancer Studies (8 papers), Cancer-related Molecular Pathways (7 papers) and RNA modifications and cancer (7 papers). Narin Voravud is often cited by papers focused on Head and Neck Cancer Studies (8 papers), Cancer-related Molecular Pathways (7 papers) and RNA modifications and cancer (7 papers). Narin Voravud collaborates with scholars based in Thailand, United States and Malaysia. Narin Voravud's co-authors include Apiwat Mutirangura, Virote Sriuranpong, Wichai Pornthanakasem, Pakpoom Supiyaphun, Pisit Tangkijvanich, Narisorn Kongruttanachok, Dong M. Shin, WN Hittelman, Attaphol Pawarode and Saowanee Yenrudi and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Oncogene and Clinical Cancer Research.

In The Last Decade

Narin Voravud

63 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Narin Voravud Thailand 23 833 700 408 375 298 65 2.0k
Andreas Karameris Greece 27 868 1.0× 738 1.1× 474 1.2× 630 1.7× 214 0.7× 119 2.5k
Inga Wedemeyer Germany 18 573 0.7× 266 0.4× 489 1.2× 280 0.7× 550 1.8× 30 1.5k
Li-Zhen Chen China 22 587 0.7× 798 1.1× 500 1.2× 236 0.6× 200 0.7× 38 1.7k
Yi Wei China 25 312 0.4× 488 0.7× 181 0.4× 379 1.0× 363 1.2× 112 1.7k
William A. Kokal United States 17 352 0.4× 657 0.9× 238 0.6× 510 1.4× 61 0.2× 25 1.5k
E. Van Marck Belgium 23 610 0.7× 695 1.0× 398 1.0× 259 0.7× 200 0.7× 59 1.8k
Ludwig Wilkens Germany 20 572 0.7× 354 0.5× 356 0.9× 462 1.2× 155 0.5× 56 1.3k
J Maestre Spain 14 706 0.8× 1.1k 1.5× 272 0.7× 382 1.0× 228 0.8× 26 2.5k
Pantaleo Bufo Italy 33 1.2k 1.4× 784 1.1× 522 1.3× 621 1.7× 263 0.9× 110 2.9k
Chang Suk Kang South Korea 24 691 0.8× 443 0.6× 274 0.7× 355 0.9× 169 0.6× 107 1.7k

Countries citing papers authored by Narin Voravud

Since Specialization
Citations

This map shows the geographic impact of Narin Voravud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narin Voravud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narin Voravud more than expected).

Fields of papers citing papers by Narin Voravud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narin Voravud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narin Voravud. The network helps show where Narin Voravud may publish in the future.

Co-authorship network of co-authors of Narin Voravud

This figure shows the co-authorship network connecting the top 25 collaborators of Narin Voravud. A scholar is included among the top collaborators of Narin Voravud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narin Voravud. Narin Voravud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Voravud, Narin, et al.. (2019). Validation of the Scored Patient-Generated Subjective Global Assessment (PG-SGA) in Thai Setting and Association with Nutritional Parameters in Cancer Patients. Asian Pacific Journal of Cancer Prevention. 20(4). 1249–1255. 26 indexed citations
3.
Voravud, Narin, et al.. (2012). Prevalence of CYP2D6*10 Genotype in Thai Breast Cancer Patients. 65(2). 113–118. 2 indexed citations
4.
Chalermchai, Thep, et al.. (2010). Randomized trial of two different doses of pyridoxine in the prevention of capecitabine‐associated palmar‐plantar erythrodysesthesia. Asia-Pacific Journal of Clinical Oncology. 6(3). 155–160. 23 indexed citations
5.
Sriuranpong, Virote, Chavit Chantranuwat, Thep Chalermchai, et al.. (2005). High frequency of mutation of epidermal growth factor receptor in lung adenocarcinoma in Thailand. Cancer Letters. 239(2). 292–297. 25 indexed citations
6.
Sriuranpong, Virote, Apiwat Mutirangura, John W. Gillespie, et al.. (2004). Global Gene Expression Profile of Nasopharyngeal Carcinoma by Laser Capture Microdissection and Complementary DNA Microarrays. Clinical Cancer Research. 10(15). 4944–4958. 74 indexed citations
7.
Kongruttanachok, Narisorn, Kanjana Shotelersuk, Pakpoom Supiyaphun, et al.. (2003). Polymeric immunoglobulin receptor polymorphisms and risk of nasopharyngeal cancer. BMC Genetics. 4(1). 3–3. 29 indexed citations
8.
Pornthanakasem, Wichai, Kanjana Shotelersuk, Wichai Termrungruanglert, et al.. (2001). Human papillomavirus DNA in plasma of patients with cervical cancer. BMC Cancer. 1(1). 2–2. 94 indexed citations
10.
Tangkijvanich, Pisit, et al.. (2001). Clinical significance of p53 antigen and anti-p53 antibodies in the sera of hepatocellular carcinoma patients. Journal of Gastroenterology. 36(12). 830–836. 24 indexed citations
11.
Kongruttanachok, Narisorn, et al.. (2001). Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study. BMC Cancer. 1(1). 4–4. 54 indexed citations
12.
Mutirangura, Apiwat, Shanop Shuangshoti, Wichai Pornthanakasem, et al.. (1999). Identification of distinct regions of allelic loss on chromosome 13q in nasopharyngeal cancer from paraffin embedded tissues. International Journal of Cancer. 83(2). 210–214. 17 indexed citations
14.
Mutirangura, Apiwat, Wichai Pornthanakasem, Virote Sriuranpong, Pakpoom Supiyaphun, & Narin Voravud. (1998). Loss of heterozygosity on chromosome 14 in nasopharyngeal carcinoma. International Journal of Cancer. 78(2). 153–156. 53 indexed citations
15.
Mutirangura, Apiwat, et al.. (1998). Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions. British Journal of Cancer. 78(7). 933–939. 41 indexed citations
16.
Mutirangura, Apiwat, Wichai Pornthanakasem, Virote Sriuranpong, et al.. (1997). Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection. British Journal of Cancer. 76(6). 770–776. 65 indexed citations
17.
Voravud, Narin, Adel K. El‐Naggar, Charles M. Balch, & Richard L. Theriault. (1992). Metastatic Lobular Breast Carcinoma Simulating Primary Colon Cancer. American Journal of Clinical Oncology. 15(4). 365–365. 14 indexed citations
18.
Voravud, Narin, Richard L. Theriault, & Gabriel Hortobagyi. (1992). Vertebral Osteomyelitis Mimicking Bone Metastasis in Breast Cancer Patients. American Journal of Clinical Oncology. 15(5). 428–432. 10 indexed citations
19.
Voravud, Narin, Meletios Α. Dimopoulos, Gabriel Hortobagyi, Merrick I. Ross, & Richard L. Theriault. (1991). Breast cancer and second primary ovarian cancer in dermatomyositis. Gynecologic Oncology. 43(3). 286–290. 11 indexed citations
20.
Voravud, Narin, Christopher S. Foster, Janet A. Gilbertson, Karol Sikora, & Jonathan Waxman. (1989). Oncogene expression in cholangiocarcinoma and in normal hepatic development. Human Pathology. 20(12). 1163–1168. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026